(Reuters) – Elon Musk’s brain-chip startup Neuralink said on Tuesday its implant had received the U.S. Food and Drug Administration’s “breakthrough device” designation.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta)
(Reuters) – Elon Musk’s brain-chip startup Neuralink said on Tuesday its implant had received the U.S. Food and Drug Administration’s “breakthrough device” designation.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta)
Comments